Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Income towards Parent Company (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Income towards Parent Company for 3 consecutive years, with -$34.2 million as the latest value for Q1 2026.

  • Quarterly Income towards Parent Company fell 57.02% to -$34.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$135.6 million through Jan 2026, down 1310.86% year-over-year, with the annual reading at -$105.6 million for FY2025, 463.06% down from the prior year.
  • Income towards Parent Company for Q1 2026 was -$34.2 million at Kestra Medical Technologies, down from -$32.8 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $53.1 million in Q2 2024, with the low at -$42.8 million in Q2 2025.
  • Average Income towards Parent Company over 3 years is -$18.5 million, with a median of -$21.8 million recorded in 2025.
  • Peak annual rise in Income towards Parent Company hit 0.65% in 2025, while the deepest fall reached 180.71% in 2025.
  • Over 3 years, Income towards Parent Company stood at -$20.6 million in 2024, then plummeted by 58.99% to -$32.8 million in 2025, then fell by 4.21% to -$34.2 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods came in at -$34.2 million, -$32.8 million, and -$25.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.